We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk.
- Authors
Venetsanopoulou, Aliki I.; Pelechas, Eleftherios; Voulgari, Paraskevi V.; Drosos, Alexandros A.
- Abstract
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation that, if left untreated, can cause joint destruction and physical impairments. The inflammatory process is systematic, and it is associated with increased morbidity and mortality. Over the last years, mortality presents a decreasing trend; still, there is a high burden of cardiovascular disease (CVD) in RA that seems to be related to coronary atherosclerosis. Chronic inflammation, physical inactivity, and drugs used to treat RA are some of the reasons. Thus, the management of CVD risk is essential and involves the patient's stratification using distinct parameters that include assessment of the blood lipid profile. However, 'dyslipidemia' in RA patients follows a different pattern under the impact of inflammatory processes, while therapies that target the underlying disease change the levels of specific lipid components. In this review, we explore the relationship between blood lipids and inflammation in the so-called ΄lipid paradox΄ in RA, and we present the existing knowledge over the influence of antirheumatic drugs on the lipid profile of RA patients.
- Subjects
RHEUMATOID arthritis; BLOOD lipids; INFLAMMATION; LIPIDS; CARDIOVASCULAR diseases; DYSLIPIDEMIA
- Publication
Rheumatology International, 2020, Vol 40, Issue 8, p1181
- ISSN
0172-8172
- Publication type
Academic Journal
- DOI
10.1007/s00296-020-04616-2